HARROW, INC. — Director's Dealing 2020

Jun 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-06-02

Reporting Person: Opaleye Management Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-02	Common Stock, par value $0.0001 per share	P	19400	$5.6876	Acquired	2519400	Indirect
2020-06-03	Common Stock, par value $0.0001 per share	P	20600	$5.7431	Acquired	2540000	Indirect
2020-06-04	Common Stock, par value $0.0001 per share	P	10000	$5.7861	Acquired	2550000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001 per share	125000	Indirect

Footnotes

F1: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.6876. The range of purchase prices on the transaction date was $5.4873 to $5.757 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F2: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

F3: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.7431. The range of purchase prices on the transaction date was $5.70 to $5.79 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F4: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.7861. The range of purchase prices on the transaction date was $5.6475 to $5.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F5: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.